Suppr超能文献

从巴西两家医院的住院患者和门诊患者中分离出的临床和肠道肠球菌的表型和基因型特征

Phenotypic and genotypic characterization of clinical and intestinal enterococci isolated from inpatients and outpatients in two Brazilian hospitals.

作者信息

Mondino Silvia S B, Castro Angela C D, Mondino Pedro J J, Carvalho Maria da Glória S, Silva Katia M F, Teixeira Lúcia M

机构信息

Departamento de Microbiologia Médica, Instituto de Microbiologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-590, Brazil.

出版信息

Microb Drug Resist. 2003 Summer;9(2):167-74. doi: 10.1089/107662903765826769.

Abstract

The phenotypic and genotypic characteristics of clinical and intestinal enterococcal isolates recovered from inpatients and outpatients of two Brazilian hospitals, located in Niterói city, Rio de Janeiro, Brazil, were compared. A total of 601 strains were studied, including 253 isolated from different clinical sources and 348 intestinal strains (205 isolated from inpatients and 143 from outpatients) recovered from fecal specimens. Isolates were identified by using conventional physiological tests and evaluated for high-level resistance to aminoglycosides (HLR-A) and resistance to vancomycin and ampicillin by the agar screening technique. Susceptibility to several antimicrobial agents was evaluated by the disk diffusion method. The genetic diversity of Enterococcus faecalis strains presenting HLR-A was assessed by pulsed-field gel electrophoresis of chromosomal DNA after SmaI digestion. E. faecalis was the most frequent species among clinical isolates (90.1%) and intestinal strains from inpatients (53.6%). E. casseliflavus was the prevalent species among intestinal isolates from outpatients (35.0%). Clinical isolates were shown to be resistant to erythromycin (53.0%), tetracycline (52.2%), ciprofloxacin (36.4%), gentamicin (36.4%), streptomycin (30.4%), chloramphenicol (34.4%), norfloxacin (32.0%), imipenem (3.2%), and ampicillin (2.8%). Vancomycin resistance was only detected in intrinsic vancomycin-resistant enterococcal species. The overall prevalence of HLR-A was 52.2% among clinical isolates and 40.5% among intestinal strains. However, HLR-A was significantly more frequent among intestinal strains obtained from inpatients (56.6%) than among strains from outpatients (17.5%). Three major clonal groups were found among E. faecalis strains exhibiting HLR-GE or HLR-GE/ST (clonal groups GE-A and GE-B), and strains exhibiting HLR-ST (clonal group ST-A). HLR-A, particularly HLR-GE, was most frequently associated with enterococcal strains of nosocomial origin. Isolates included in the major clonal groups were recovered from clinical and intestinal sources from patients in both hospitals, indicating both intrahospital and interhospital spread of strains.

摘要

对从巴西里约热内卢尼泰罗伊市两家医院的住院患者和门诊患者中分离出的临床和肠道肠球菌菌株的表型和基因型特征进行了比较。共研究了601株菌株,包括从不同临床来源分离出的253株以及从粪便标本中分离出的348株肠道菌株(205株来自住院患者,143株来自门诊患者)。通过常规生理试验鉴定分离株,并采用琼脂筛选技术评估其对氨基糖苷类高水平耐药(HLR-A)以及对万古霉素和氨苄西林的耐药性。采用纸片扩散法评估对几种抗菌药物的敏感性。对呈现HLR-A的粪肠球菌菌株的遗传多样性通过SmaI消化后染色体DNA的脉冲场凝胶电泳进行评估。粪肠球菌是临床分离株(90.1%)和住院患者肠道菌株(53.6%)中最常见的菌种。格氏肠球菌是门诊患者肠道分离株中最常见的菌种(35.0%)。临床分离株显示对红霉素(53.0%)、四环素(52.2%)、环丙沙星(36.4%)、庆大霉素(36.4%)、链霉素(30.4%)、氯霉素(34.4%)、诺氟沙星(32.0%)、亚胺培南(3.2%)和氨苄西林(2.8%)耐药。万古霉素耐药仅在固有万古霉素耐药肠球菌菌种中检测到。HLR-A在临床分离株中的总体患病率为52.2%,在肠道菌株中为40.5%。然而,HLR-A在从住院患者获得的肠道菌株中(56.6%)比在门诊患者菌株中(17.5%)更为常见。在呈现HLR-GE或HLR-GE/ST的粪肠球菌菌株(克隆群GE-A和GE-B)以及呈现HLR-ST的菌株(克隆群ST-A)中发现了三个主要克隆群。HLR-A,特别是HLR-GE,最常与医院来源的肠球菌菌株相关。主要克隆群中的分离株从两家医院患者的临床和肠道来源中均有回收,表明菌株在医院内和医院间均有传播。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验